Molecular and cellular mechanisms of pulmonary fibrosis

@inproceedings{Todd2012MolecularAC,
  title={Molecular and cellular mechanisms of pulmonary fibrosis},
  author={Nevins W. Todd and Irina G. Luzina and Sergei P. Atamas},
  booktitle={Fibrogenesis & tissue repair},
  year={2012}
}
Pulmonary fibrosis is a chronic lung disease characterized by excessive accumulation of extracellular matrix (ECM) and remodeling of the lung architecture. Idiopathic pulmonary fibrosis is considered the most common and severe form of the disease, with a median survival of approximately three years and no proven effective therapy. Despite the fact that effective treatments are absent and the precise mechanisms that drive fibrosis in most patients remain incompletely understood, an extensive… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 90 extracted citations

Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress

BMC complementary and alternative medicine • 2014
View 5 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 327 references

Glucocorticosteroids: current and future directions.

British journal of pharmacology • 2011
View 5 Excerpts
Highly Influenced

Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.

American journal of respiratory and critical care medicine • 2011
View 9 Excerpts
Highly Influenced

Intratracheal gene transfer of tissue factor pathway inhibitor attenuates pulmonary fibrosis.

Biochemical and biophysical research communications • 2006
View 17 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…